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http://dx.doi.org/10.1016/j.fjs.2013.Summary Most surgeons dream about performing an extensive resection with a wide resec-
tion margin and extensive lymph nodes dissection, which will yield a favorable prognosis. Pre-
vious studies have reported varying lengths of the margins based on different clinical profiles.
The so-called safety margin is not completely safe because limited scientific evidence exists
for nonrecurrence, even after the patient has had a pathological examination to prove a nega-
tive cancer invasion at the resection margin. The safety margins for malignancy are different in
the esophagus, stomach, colorectum, liver, and others because of the different modes of
carcinogenesis and variable paths of recurrence. However, a minimally acceptable margin
length can be defined because the margin is destroyed during operative dissection or short-
ened after formalin fixation for tissue assessment during pathological diagnosis. The currently
available data for supporting the reality of a true negative or true positive invasion at the
resection margin could be presumed by gross findings of a solid tumor. A safety margin for
esophageal, gastric, liver, and colorectal cancer could be 0.1, 2e4, 2, and 1e3 cm, respec-
tively. A dream to have a real safety surgical margin to achieve better surgical outcome is a
challenge for any gastroenterological surgeon. However, a complete safety margin may not al-
ways be realized because it is impossible to have a true negative margin from surgical equip-
ment and pathological tissue process.
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The role of a surgical margin in surgical oncology has always
been discussed with regard to the tumor recurrence and
survival rate in gastrointestinal cancer surgery. Previous
reports have suggested that extensive operation with a
wide resection margin and extensive lymph node dissection
will probably result in a better prognosis.1e4 According tociation. Published by Elsevier Taiwan LLC. All rights reserved.
84 C.-G. Kerthe “seed-and-soil theory”, during the carcinogenesis of
liver tumor, less liver parenchyma will mean less likelihood
of recurrence. As a result, extensive liver resection for
primary liver cancer is usually encouraged if liver function
is preserved.5e7 In the report by Poon et al,8 extended
hepatic resection for hepatocellular carcinoma (HCC) with
cirrhosis needed to be justified depending on the preserved
liver function. Besides, there were no significant differ-
ences in the incidence of hepatic failure, complication
rate, and resection margin width between the groups un-
dergoing extended or lesser extended hepatectomy for
HCC. The role of the surgical margin width in a hepatec-
tomy for HCC was explained by Shimada et al,9 and it was
suggested to secure a surgical margin >10 mm in young
patients without hepatitis C virus infection and/or a tumor
size of 25 mm or larger after a macroscopic curative hep-
atectomy to achieve long-term disease-free survival.
However, differences exist with regard to the role of
surgical margin. For example, the “1-cm rule” for distal
rectal cancer surgery refers to distal bowel margin as
measured by surgeons on the fresh anatomically restored
ex vivo condition, as reported by Bujko et al.10 The bias in
measurement could be induced by the measuring patholo-
gist on either the fresh tissue or on formalin-fixed speci-
mens. Because of the bowel shrinkage occurring soon after
the removal from the patient’s abdomen and the additional
shrinkage occurring after fixation, correction factors have
been proposed to account for the shrinkage of the distal
margin. In addition, because the measurements were based
on histological assessment during pathologic evaluation and
not routinely by the surgeon’s operative findings, the re-
sults of the previous report10 should be considered taking
this limitation into account, which may induce a potential
source of bias.
Safety surgical margin of each organ in gastroenterologic
cancer will have different recurrence and/or survival rates.
In addition, the length of safety surgical margin cannot be
firmly set with regard to the various organs. Actually, no
impairment in the oncologic safety margin is expected
owing to the differences that exist, as a negative or an
ultraclosed negative will yield a totally different surgical
outcome.2. Surgical margin in esophagus cancer
The prognostic role and definition of the circumferential
resection margin (CRM) involvement in operable esophageal
cancer remain controversial. The College of American Pa-
thologists and Royal College of Pathologists define CRM
involvement as a tumor found at the cut resection margin
and a tumor within 1 mm of the cut margin, respectively. A
systematic review and meta-analysis was performed to
determine the influence of CRM involvement on survival in
operable esophageal cancer.11 In this previous study by
Chan et al, 2433 patients with esophageal cancer who had
undergone potentially curative esophagectomy were
analyzed in 14 reports. The CRM involvement between 0.1
and 1 mm was associated with a significantly higher 5-year
mortality rate than the CRM-negative status (p < 0$001).
Thus it was concluded that CRM involvement is an impor-
tant predictor of esophageal cancer prognosis. Microscopictumor infiltration of the resection margin after esophageal
resection is implicated to influence anastomotic leakage,
tumor recurrence rates, and long-term survival. Law et al
compared patients with tumor infiltration of resection
margin (RMþ) and those without infiltration (RM).12 Of the
total 604 patients analyzed in the study, anastomotic re-
currences developed in 10.3% of the patients in the RMþ
group and in 4.9% of the patients in the RMe group without
significant difference. Although a positive margin did not
increase anastomotic recurrence, median survival time was
significant different. However, in another study by Dexter
et al,13 the odds ratio for the risk of dying from esophageal
cancer was 2.08 when the CRM was involved (p Z 0.013).
Therefore, the presence of tumor within 1 mm of the
circumferential margin following potentially curative
resection for esophageal carcinoma is an important inde-
pendent prognostic variable, and thus, it should be
routinely reported.3. Surgical margin in gastric cancer
The effect of positive or negative resection margin on the
prognosis of gastric cancer was recognized and debated for
decades. In a retrospective study by Chen et al,14 64
advanced gastric cancer patients with positive resection
margin after potentially curative resection were investi-
gated for the prognostic effect of postoperative resection
margin status for intraoperative positive resection margins.
The survival between those patients who were re-excised
to a negative resection margin and those who were left
with positive resection margin was compared. The median
survival in the positive resection margin group was 17.0
months as compared with 23.0 months in the negative
resection margin group (p Z 0.045). Thus, re-excision for
an intraoperatively positive margin to a negative margin as
a standard, can improve the prognosis of the patients with
advanced gastric cancer. Therefore, routine frozen section
examination of the resection margins should be made
mandatory in all advanced gastric cancer patients under-
going potentially curative surgery. However, it is necessary
to discuss how far is adequate to avoid the positive resec-
tion margin. In fact, the incidence of infiltration of the
proximal edge was significantly higher when the tumor
penetrated the serosa layer or spread beyond it than when
the lesion was confined to the mucosal, submucosal, or
muscular layer.1 With reference to the length of the
resection margin, no involvement was found when the
cranial distance between the lesion and the line of resec-
tion was 6 cm. Proximal or distal infiltration for a distance
>3 cm did not occur in patients with lesions confined to the
mucosal, submucosal, and muscular layers. With regard to
the length of the resection margin, no involvement was
found when the cranial distance between the lesion and the
line of transection exceeded 2 cm in patients with orally
well-defined-type esophageal invasion. However, in pa-
tients with orally ill-defined type, transection with a dis-
tance >4 cm commonly guarantees safety of the proximal
margin, except for cases with lymphatic invasion.15 These
data provide a gastric surgeon with a rational basis for
assessing the extent of resection while performing gas-
trectomy for gastric cancer.
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junction (GEJ), the length of esophageal resection or the
operative approach influences the outcome of the patients.
A multivariable analysis in patients who underwent R0
resection with lymph nodes examinations revealed that the
number of positive lymph nodes, T stage, tumor grade, and
ex vivo proximal margin length >3.8 cm were independent
prognostic factors.16 In addition, the study reported that in
patients not receiving neoadjuvant therapy, the goal for
patients with adenocarcinoma of the GEJ should be R0
resection including at least 15 lymph nodes, preferably with
5 cm of grossly normal in situ proximal esophagus for those
with six or less positive lymph nodes. Therefore, in order to
achieve better results it should be individualized to decide
the esophageal resection margin and operative approach.
4. Surgical margin in primary and secondary
liver cancer
4.1. HCC
There was no significant difference on the overall survival
rate and disease-free survival rate in patients with HCC who
received major or limited open resection.17 Therefore,
major hepatectomy was not recommended for patients
with solitary small HCC measuring 3 cm or less in diameter
in the series of Shimada et al.6 In a retrospective study on
patients who underwent laparoscopic liver resection for
HCC, no significant difference was observed in the overall
survival rate between the major hepatectomy (2 segments
or more) and the minor hepatectomy group (1 segment or
less).18 However, postoperative tumor recurrence was
commonly found in patients with HCC, and no promising
methods for prevention of recurrence exist. The effect of
surgical resections with wide margins on tumor recurrence
and survival rates remains controversial. In a study by Yu
et al,19 HCC patients treated by open resection with a
tumor resection margin <5 mm had a poorer prognosis of
the intrahepatic recurrence. The influence of surgical
safety margin while performing traditional open laparot-
omy was also discussed in a few studies.20e23 Without any
doubt, laparoscopic liver surgery has advantages over the
traditional open procedure in selected patients.24 However,
owing to the lack of an operator’s finger feeling during a
laparoscopic approach, it is somewhat difficult to keep a
safety margin far from the resection plain during liver
dissection. In an unpublished study, the 1-, 3-, and 5-year
survival rates were 84.2%, 67.3%, 57.7% and 93.3%, 86.7%,
78.0% for operating on HCC patients with safety margins of
5e9 mm or 10 mm, respectively, with a nonsignificant
difference (p Z 0.139). Our retrograde evaluation of the
clinical significance in those patients who underwent either
laparoscopic or traditional liver resection for tumor located
at the anterior aspects of HCC revealed a nonsignificant
difference based on case-matched analysis.18 Therefore,
based on previous reports21,25 and our experiences,18,26 it
can be concluded that a surgical margin set at the level of
1 cm will be adequate for liver cancer surgery. In a pro-
spective randomized trial, Shi et al27 compared the efficacy
and safety of partial hepatectomy aiming grossly at a wide
and narrow resection margin in patients withmacroscopically solitary HCC. The study results revealed
that a resection margin aiming grossly at 2 cm efficaciously
decreased postoperative recurrence rate and improved
survival outcomes when compared with a gross resection
margin aiming at 1 cm, especially for HCCs measuring
2 cm. However, surgeons usually hesitate to perform
major liver resection in patients with severe liver cirrhosis,
because the patients could die due to poor remnant liver
function. In situations where a tumor is located near the
area of porta hepatis or close to the main blood vessels or
bile duct, it is impossible to have the surgical margin
>1 cm. Qin and Tang28 reported no significant difference in
the survival rates between the HCC patients who received
different extensions of liver resection. Therefore, it is not
necessary to try to have an extended safety surgical margin
for patients with obvious liver cirrhosis. It is, however, true
that a wide resection margin will minimize potential
microscopic invasion, subsequently resulting in better sur-
vival rates.29,30
4.2. Cholangiocellular carcinoma
Theoretically, an anatomic liver resection with a wider
resection margin gives a higher potential for curing HCC or
cholangiocellular carcinoma (CCC). However, preserving
nontumor liver parenchyma is an important issue to avoid
postoperative hepatic failure, especially in patients with
cirrhotic liver. The optimal liver resection margin for CCC is
still controversial. A resection margin of 2 cm is associated
with a decreased postoperative recurrence rate and
improved survival outcomes.29 Hepatic resection, whenever
technically possible, should be enforced because the pre-
operative pathological diagnosis of HCC or CCC is difficult
and the next treatment option needs to be clear. However,
the expected narrow hepatic resection margins should not
discourage patients from undergoing potentially curative
surgery or hoping for long-term survival. In case of hilar
cholangiocarcinoma, a radical resection has been shown to
be the only parameter with a significant impact on survival.
Extended hepatectomy seems to give the best oncologic
results. A surgical margin <1 cm after the resection should
not be used as an exclusion criterion for resection and it
will not impair patients’ prognosis. Resection should be
performed irrespective of the width of the surgical margin.
In another study by Ribero and the Italian Intrahepatic
Cholangiocarcinoma Study Group,31 a total of 434 patients
were included and underwent a major or extended hepa-
tectomy (70.0%) and a systematic lymphadenectomy
(62.2%). The median time of survival in these patients was
39 months, and the 5-year survival rate was 39.8%.
Conversely, survival was not influenced by the width of a
negative resection margin (p Z 0.61).
4.3. Liver metastasis tumor from colorectal cancer
With regard to the safety surgical margin for metastatic
liver tumor from colorectal cancer, a safety margin 1 cm
is generally accepted in liver surgery for colorectal me-
tastases. However, modern methods of liver parenchyma
dissection may allow for a reduction in this distance and a
1e3-mm margin is considered safe.32,33 In the study by
86 C.-G. KerKonopke et al, 333 patients were included in a multicenter
trial after resection of colorectal liver metastases.33 An
analysis of different groups denoting the extent of resec-
tion margin [10, 6e9, 3e5, 1e2, and 0 mm (R1)] indicated
that a margin of 1e2 mm leads to a significantly reduced
median hepatic recurrence-free survival of 20 months
(p Z 0.004) and recurrence-free survival of 19 months
(p Z 0.011). Surgical margins were significantly reduced in
simultaneous resections of four or more liver metastases
and in cases in which metastatic infiltration of central liver
segments was present. The indication for resection of me-
tastases can also be safely extended to tumors that are
located within 1 cm to nonresectable structures.
Patients who fail to achieve 1-cm margin are routinely
treated with edge cryotherapy, as reported by Hou et al.32
They tried to evaluate the benefit of edge cryotherapy on
survival in 608 patients with optimal margins <1 mm. As
long as the surgical margin is clear macroscopically, the
width of the microscopic margin does not affect the pa-
tient’s survival. In patients with suboptimal margins, the
additional edge cryotherapy will improve the prospect for
long-term survival and may lower recurrence risk. If an
unsafe surgical margin is noted during the perioperative
period, we recommend using cryotherapy or performing
cauterization with heat probe to treat the risky margin in
order to achieve a better prognosis. Table 1 presents the
results of surgical margin for cancer surgery from the
literature.5. Surgical margin in colorectal cancer
The Japanese general rules for clinical and pathologic
studies on cancer of the colon, rectum, and anus state that
a 3-cm distal resection margin is needed in rectosigmoid
cancer and rectal cancer with a distal edge above the
peritoneal reflection, and a 2-cm margin is needed for
rectal cancer with a distal edge below the peritoneal
reflection.34 In a study of 381 patients by Shimada et al,34
the maximum extent of distal spread in patients with rec-
tosigmoid cancer or rectal cancer with the distal edgeTable 1 Surgical margin for cancer surgery from the
literature sources.
Anatomic site Surgical
margin
Authors
Esophagus 0.1 cm Chan et al11
Gastroesophageal
junction
5 cm Barbour et al16
Stomach
(proximal end)
2e4 cm Tsujitani et al15
Colon 3 cm Shimada et al34
Rectum 1e2 cm Bujko et al,10 Moore et al35
Liver
HCC 1 cm Shi et al,27 Ker et al18
CCC 2 cm Salloum and Castaing29
CLM 1e3 mm Hou et al,32 Konopke et al33
CCC Z cholangiocellular carcinoma; CLM Z colorectal cancer
metastasis; HCC Z hepatocellular carcinoma.above the peritoneal reflection was 3.8 cm, whereas it was
3.5 cm in patients with rectal cancer with the distal edge
below the peritoneal reflection. Therefore, a further in-
crease of 1e2 cm beyond the recommended distal resection
margin may contribute to improved local control for pa-
tients with distant metastasis.
The major point for colorectal cancer surgery is to
include resection of the regional lymph node and mesen-
terium in addition to the colorectum. For patients with
rectal cancer, the adequacy of the distal margin is depen-
dent on both the risk for intramural tumor spread and the
distal mesorectal lymphatic spread. Tumor cell deposits
within the mesorectal lymph nodes have been identified up
to 5 cm distal to the inferior aspect of the tumor, empha-
sizing the need to adhere to the principles of total meso-
rectal excision and giving rise to the concept of tumor-
specific mesorectal excision (mesorectal transection 5 cm
distal to the inferior border of the tumor) for more proximal
rectal cancers. A systematic review of studies by Bujko et al
identified 17 studies showing results in relation to margins
of approximately <1 cm (948 patients) versus >1 cm (4626
patients); five studies in relation to a margin 5 mm (173
patients) versus >5 mm (1277 patients), and five studies
showing results in a margin 2 mm (73 patients). The local
recurrence rate was 1.0% higher in the <1-cm margin group
compared with the >1-cm margin group (pZ 0.175). In the
selected group of patients, <1-cm margin did not jeopar-
dize oncologic safety after sphincter-preserving surgery for
rectal cancer, which was also the same conclusion in
another report.35 It was suggested that the safety margin
may be reduced to 1 cm or even 0.5 cm by preoperative
radiotherapy.36,37 Therefore, preoperative radiotherapy
may extend the indications for a sphincter-saving opera-
tion. However, a report by Kwak et al suggested that a
distal margin of at least 5 mm with a negative resection
margin on frozen section examination does not reduce
oncological safety in patients with rectal cancer who
receive preoperative or postoperative chemo-
radiotherapy.38 The length will be shorter if the patient
undergoes additional treatment along with preoperative
radiation. However, there is no excuse for the extension of
the resection of mesocolon no matter how short the
resection margin is from the tumor.6. Discussion
In general, wide excision of a malignant tumor with an
adequate margin is important to ensure disease eradication
and recurrence. The existing evidence is based on patho-
logical findings to determine a positive or negative safety
margin or involvement of a tumor capsule. However, one
thin slice of pathological tissue cannot represent the entire
resection margin tissue, meaning the positive or negative
result obtained may or may not be correct. Therefore, it is
difficult to truly ascertain the condition, because the actual
status cannot be obtained by pathological findings on a thin
slide, especially when using a false-negative resection
margin. In this situation, false-negative results will be high,
because the entire tissue around the tumor resection
margin is not examined. In addition, skip metastatic lesion
or bloodstream metastatic cancer is commonly found while
Safety margin in GI surgery 87performing an oncological surgery in our patients as shown
in the Fig. 1. Such a concept may also be applicable to HCC,
which is characterized by unique pathologic features.
Intrahepatic spread mainly occurs by portal venous inva-
sion, which is completely different from the invasion of
tumors into the surrounding tissues. Multicentric recur-
rence is common in HCC and could occur anywhere in the
liver remnant.39 The relation between the resection margin
and the pattern of recurrence shows that in both the nar-
row and wide margin groups, most recurrences occurred in
the liver remnant at a distal segment or multiple segments,
indicating an origin from either intrahepatic metastasis or
multicentric carcinogenesis.8,26 The margin width did not
have prognostic significance in relation to the underlying
liver cirrhotic status or the extent of resection. This has an
important implication for avoiding extensive resection of
HCC associated with cirrhosis. Without question, a positive
histological margin is associated with a higher incidence of
postoperative recurrence, but a postoperative recurrence
could be related to the underlying venous invasion or
microsatellites rather than the resection margin. Most
intrahepatic recurrences were considered to arise from
intrahepatic metastasis by venous dissemination, which a
wide resection margin could not prevent. Although sur-
geons would prefer to have a wide margin to achieve a
better prognosis, various factors exist based on the path of
carcinogenesis.
Although the prognosis of resected esophageal cancer
has improved over the last decade, long-term survival re-
mains poor. A large-scale study on the CRM involvement was
performed by Dexter et al,13 who analyzed a cohort of 135
potentially curative esophagectomies. They demonstrated
that CRM involvement was a significant adverse predictor of
survival and an independent prognostic variable. By
contrast, Hulscher et al40 suggested that CRM involvement
was not an independent prognostic predictor, but the sur-
gical technique is itself a determinant of disease recur-
rence. However, the TNM stage will affect the results of
CRM involvement.13,41 In addition, it should be noted that
routine neoadjuvant chemotherapy has become theFigure 1 Foci of liver cancer cells (arrow) founded with a
skip distance from the main tumor (T; alpha feto-protein stain,
magnification Z 100).standard treatment for surgically resectable esophageal
cancer. Sujendran et al42 examined a cohort of 242 patients
who underwent esophagectomy, in which approximately
60% or more had neoadjuvant chemotherapy. They had
mentioned that CRM involvement was an independent
adverse prognostic factor in patients who had surgery alone
as well as in those who underwent preoperative chemo-
therapy followed by surgery. The study reported that the
improvement in survival in patients who underwent pre-
operative chemotherapy as compared with surgery alone
could be attributed to a decrease in the rate of CRM posi-
tivity in the neoadjuvant group. Nonetheless, there is
accumulating evidence that CRM involvement in the era of
routine preoperative chemotherapy is an important prog-
nostic factor following esophagectomy for cancer.
The principles of surgical treatment for primary and
secondary liver tumor were different. The general concept
of a safety margin is 1 cm in HCC surgery. Ueno et al43
performed a retrospective cohort study in 116 consecutive
patients who underwent curative hepatic resection for
HCCs, and the results indicated that the anatomic resection
was more prominent in the group with the nonboundary-
type nodules (single nodular type with extranodular
growth, confluent multinodular type, and invasive type)
than in the group with the boundary type (vaguely nodular
and single nodular type). Micrometastases in the non-
boundary type were found further from the main tumor
(9.5  6.2 mm) than those in the boundary type (within
3.1  1.4 mm). Therefore, in patients with HCC nodules
3 cm and with the nonboundary type, the anatomic
resection should be performed, because this procedure
would be more favorable than the nonanatomic resection in
eradicating micrometastases that have extended away
from the tumor’s margin. This is the reason why anatomic
resection was encouraged to have safety margin in primary
liver tumor if liver function allows.
Concerning the metastatic liver tumor from colorectal
cancer, margin status remains an important determinant of
survival after surgical resection. Andreou et al44 reported
on the impact of surgical margin status on the overall sur-
vival in 378 patients undergoing hepatectomy for colorectal
liver metastases after modern preoperative chemotherapy.
The survival benefit associated with negative margins (R0
vs. R1 resection) was greater in patients with suboptimal
morphologic response (5-year overall survival rate: 62% vs.
11%; p Z 0.007). Therefore, they suggested that negative
margins remain an important determinant of survival in the
era of modern chemotherapy, and should be the primary
goal of surgical therapy. The role of positive margins is most
pronounced in patients with response to systemic therapy.
Because the liver parenchyma is destroyed by the use of
surgical equipment such as ultrasonic dissectors, which
aspirates a portion of liver parenchyma, or while perform-
ing microwave ablation between the tumor and normal
liver, it is difficult to increase the true margin. An approx-
imate margin from 1 mm to 1 cm due to transection
debridement would not be unreasonable. Hence, even
having 1 mm as the cut-off point for a microscopically clear
margin was reported previously32 and some were not in the
metastatic liver tumor resection.45,46 The part of liver pa-
renchyma destroyed during the dissection and pathological
examination just based on a thin slice of tissue will provide
88 C.-G. Kerdata on the length of surgical margin, which can be then
used as a reference, especially in cases involving false-
negative results. Therefore, the results of previous
studies on surgical margins and surgical outcomes were
quite different and controversial.
Malignant tumors in solid and bowel organs were
different with regard to tumor spreading or in tumorigen-
esis. Distal bowel intramural spread is present within 1 cm
distally from the visible tumor in a substantial proportion of
patients. For these reasons, for patients with low-lying
cancer who are undergoing anterior resection, 1 cm of
distal bowel clearance is recommended as minimally
acceptable.10 The 1-cm rule is occasionally violated,
especially after preoperative radiation or chemo-
radiotherapy may lead to tumor regression, facilitating
complete tumor resection with a <1-cm bowel margin in
patients who are otherwise candidates for abdominoper-
ineal resection.38 Surgeons should understand the true
margin while performing dissection and these results will
yield a different outcome as well. The adequacy of the
distal margin is dependent on both the risk for intramural
tumor spread and the distal mesorectal lymphatic spread in
addition to the length of surgical margin for patients of
rectal cancer. Tumor cells deposited within the mesorectal
lymph nodes have been located up to 5 cm distal to the
inferior aspect of the tumor, which emphasize the need to
adhere to the concept of tumor-specific mesorectal exci-
sion (5 cm distal to the inferior border of the tumor) for
more proximal rectal cancers. However, for patients with
low-lying tumors treated with total mesorectal excision,
the primary concern in the absence of lateral or inguinal
lymphatic metastases is distal intramural spread. There-
fore, Bujko et al10 had performed a systematic review and
proved that distal rectal margins approximately <1 cm did
not affect oncologic outcomes after sphincter-preserving
surgery for rectal cancer. It is variable to have a close
distal margin and rectal cancer recurrence after sphincter-
preserving rectal resection. Negative surgical margins are
important for local recurrence of rectal cancer treated with
sphincter-preserving surgery. However, the association of
rectal cancer recurrence with close distal margin is not well
established. In the report by Nash et al,47 pelvic recur-
rence, other than isolated mucosal recurrence, and lym-
phovascular invasion were frequently found after the rectal
cancer was treated with sphincter-preserving surgery.
Hence, the distal margin being a variable was associated
with overall recurrence. In general, close distal resection
margin identifies patients with an increased risk of mucosal
and overall cancer recurrence. Although neither causality
of tumorigenesis nor a minimally acceptable margin length
can be defined, an analysis of existing data usually supports
the importance of achieving a clear distal resection margin
in the surgical management of rectal cancer.
In conclusion, the dream of a safe surgical margin for
gastroenterological surgery has been realized, but the re-
ality is that it is not completely safe owing to the limited
scientific evidence that exists in this regard. A wide
resection margin will facilitate less recurrence, theoreti-
cally, if the recurrence is at a resection margin. Most
recurrent tumors did not occur at the margin site due to the
different type of carcinogenesis. A surgeon should try to
have a safe margin and try to ablate the tumor completely.References
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